The present invention relates to novel triazine compounds. Trie present invention also discloses compounds of formula I along with other pharmaceutical acceptable excipients and use of the compounds to modulate the PI3K/ mTOR pathway. The present invention relates to novel triazine compounds that may be useful as kinase inhibitors. More particularly, the present invention relates to substituted triazine derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of PI3K/mTOR pathway related disorders.
